Here are relevant reports on : genomic-diagnostics-market
-
Sexually Transmitted Diseases Diagnostics Market by Disease Type (CT/NG, Gonorrhea, Syphilis, Genital Herpes, Hepatitis B, HIV/AIDS, HPV), End User (Laboratory, PoC) and Geography - Global Forecast to 2027
The STDs diagnostics market size is projected to reach $99,431.6 million by 2027 from $91,441.5 million in 2022, at a CAGR of 5.6% during the forecast period. Sexually transmitted diseases diagnostics market is driven by factors such as global prevalence of HIV, CT/NG, and other STDs and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements. On the other hand, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the coming years.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Immunohistochemistry Market by Product & Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) - Global Forecast to 2030
The global immunohistochemistry market, valued at US$3.31 billion in 2024, stood at US$3.55 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$5.14 billion by the end of the period. The increasing number of cancer cases is one of the key factors driving the uptake of IHC products, which, in turn, leads to a greater need for accurate and efficient diagnostic tools such as IHC tests.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Imaging Chemicals Market by Product Type (Printing Inks, Image Developers), Application (Printing & Packaging, Medical Diagnostics, Textile Processing), and Region (North America, Europe, APAC, MEA, and South America) - Global Forecast to 2022
The imaging chemicals market is estimated to grow from USD 22.08 Billion in 2017 to USD 29.97 Billion by 2022, at a CAGR of 6.3% from 2017 to 2022. Imaging chemicals are chemicals substances that used to produce or develop photographs. The imaging chemicals market is segmented by product type, application, and region. Key companies profiled in this research report on the imaging chemicals market include Fujifilm (Japan), The Eastman Kodak Company (US), Vivimed Labs (India), DIC Corp. (Japan), Flint Group (Germany), Sakata Inx (Japan), Toyo Ink SC (Japan), Siegwerk Druckfarben (Germany), and T&K Toka (Japan).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031
The Latin America in vitro diagnostics (IVD) market, valued at USD 5.48 billion in 2025, stood at USD 5.87 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.13 billion by the end of the period. The increasing demand for diagnostic services, along with the growing need for routine and specialized testing, is driving the market. Investments in lab infrastructure, combined with the adoption of automated and standardized diagnostic procedures, contribute to increasing test volumes in both the public and private healthcare sectors.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
United States Fleet Management Market by Solutions (Operation Management, Vehicle Maintenance & Diagnostics, Performance Management, Fleet Analytics & Reporting), Fleet Type (Passenger Cabs, Commercial Vehicles, Public Transport) - Global Forecast to 2030
The fleet management market in the US is expected to reach USD 17.63 billion by 2030, up from USD 11.34 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period. The Key Players Verizon Connect (US), Trimble (US), Geotab (Canada), Wheels (US), Samsara (US), Solera (US), Teletrac Navman (US), Holman (US), ORBCOMM (US), Verra Mobility (US), Zebra Technologies (US), Motive (US), Zonar Systems (US), Azuga Inc. (US), and Tenna LLC (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Fiber Optics Collimating Lens Market by Type (Fixed and Adjustable), Wavelength, Mode (Single Mode, Multimode), Application (Communication, Medical & Diagnostics, Metrology, Spectroscopy and Microscopy), and Geography (2021-2026)
The global fiber-optics collimating lens market size is projected to reach USD 1,081 million by 2026, it is expected to grow at a CAGR of 13.3% during the forecast period. AMS Technologies AG, IPG Photonics Corporation, Coherent, Fabrinet, Thorlabs Inc, Daheng New Epoch Technology, Inc (CDHC), Edmund Optics, FS.Com, and Gooch & Housego are the major players in this market. The report also profiles the companies such as TRIOPTICS, SCANLAB GmbH, Rochester Precision Optics, LightPath Technologies, CeramOptec, Fiberguide Industries, Inc., OZ Optics, Ltd., Avantes, and Laser Mechanisms with their company profiles, recent developments, COVID-19 developments, and key market strategies.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
High Performance Liquid Chromatography Market / HPLC Market by Product (Instruments (Systems, Detectors), Consumables (Columns, Filters), and Accessories), Application (Clinical Research, Diagnostics, Forensics), Region - Global Forecast to 2025
The global high performance liquid chromatography market in terms of revenue was estimated to be worth USD 4.5 billion in 2020 and is poised to reach USD 5.7 billion by 2025, growing at a CAGR of 4.6% from 2020 to 2025. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region
The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
US Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] Forecast to 2031
The US Medical Gas and Equipment Market, valued at USD 8.18 million in 2024, stood at USD 8.63 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2031, culminating in a forecasted valuation of USD 11.97 million by the end of the period. The growth of the medical gas and equipment market in US is primarily driven by the rising incidence of respiratory and chronic diseases, including COPD, asthma, cardiovascular disorders, and sleep apnea, as well as a rapidly aging population that requires long-term oxygen therapy and critical care support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
